当前位置:首页 - 行情中心 - 戴维医疗(300314) - 财务分析

戴维医疗

(300314)

  

流通市值:20.47亿  总市值:31.13亿
流通股本:1.89亿   总股本:2.88亿

戴维医疗(300314)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.63亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益117524.71万元,未分配利润62457.46万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产133927.80万元,负债16403.09万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入402,925,721.56265,824,458.42155,328,964.53618,298,238.74
营业总成本335,740,052.47215,490,046.49108,971,100.08471,574,505.83
营业利润71,916,121.2752,899,639.0844,488,936.73171,364,659.96
利润总额71,886,109.8552,797,721.7544,430,191.57166,224,724.77
净利润63,307,872.0646,526,145.3638,107,228.76147,610,911.51
其他综合收益306,790.36-171,801.45-0
综合收益总额63,614,662.4246,354,343.9138,107,228.76147,610,911.51
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计884,870,039.81920,995,380.75964,633,245.08992,404,613.46
非流动资产合计454,407,938.83437,537,831.91400,331,425.34381,678,305.47
资产总计1,339,277,978.641,358,533,212.661,364,964,670.421,374,082,918.93
流动负债合计152,517,269.57188,950,741.4150,248,398.25197,436,542.14
非流动负债合计11,513,634.7211,595,715.4213,272,122.0913,173,964.86
负债合计164,030,904.29200,546,456.82163,520,520.34210,610,507
归属于母公司股东权益合计1,175,247,074.351,157,986,755.841,201,444,150.081,163,472,411.93
股东权益合计1,175,247,074.351,157,986,755.841,201,444,150.081,163,472,411.93
负债和股东权益合计1,339,277,978.641,358,533,212.661,364,964,670.421,374,082,918.93
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计410,191,271.93276,148,676.99149,530,386.41693,450,206.88
经营活动现金流出小计396,160,630.59275,364,059.03159,861,425.94558,251,820.87
经营活动产生的现金流量净额14,030,641.34784,617.96-10,331,039.53135,198,386.01
投资活动现金流入小计725,213,552.97362,905,368.6590,587,098.221,257,553,455.8
投资活动现金流出小计990,882,919.06597,755,931.79194,327,230.461,185,792,322.31
投资活动产生的现金流量净额-265,669,366.09-234,850,563.14-103,740,132.2471,761,133.49
筹资活动现金流入小计---0
筹资活动现金流出小计55,407,874.0821,037,798.08-45,706,578.9
筹资活动产生的现金流量净额-55,407,874.08-21,037,798.08--45,706,578.9
汇率变动对现金及现金等价物的影响-1,249,375.59238,258.36-297,651.276,327,170.64
现金及现金等价物净增加额-308,295,974.42-254,865,484.9-114,368,823.04167,580,111.24
期末现金及现金等价物余额249,160,346.16302,590,835.68443,087,497.54557,456,320.58
TOP↑